Abstract
The Gemini analogs are the last significant contribution to the family of vitamin D derivatives in medicine, for the treatment of cancer. The first Gemini analog was characterized by two symmetric side chains at C-20. Following numerous modifications, the most active analog bears a C-23-triple bond, C-26, 27- hexafluoro substituents on one side chain and a terminal trideuteromethylhydroxy group on the other side chain. This progression was possible due to improvements in the synthetic methods for the preparation of these derivatives, which allowed for increasing molecular complexity and complete diastereoselective control at C-20 and the substituted sidechains.
Keywords: Chemical synthesis, Gemini analogs, Steroid, Vitamin D.
Current Topics in Medicinal Chemistry
Title:Gemini Analogs of Vitamin D
Volume: 14 Issue: 21
Author(s): Gonzalo Pazos, Marcos L. Rivadulla, Xenxo Perez-García, Zoila Gandara and Manuel Perez
Affiliation:
Keywords: Chemical synthesis, Gemini analogs, Steroid, Vitamin D.
Abstract: The Gemini analogs are the last significant contribution to the family of vitamin D derivatives in medicine, for the treatment of cancer. The first Gemini analog was characterized by two symmetric side chains at C-20. Following numerous modifications, the most active analog bears a C-23-triple bond, C-26, 27- hexafluoro substituents on one side chain and a terminal trideuteromethylhydroxy group on the other side chain. This progression was possible due to improvements in the synthetic methods for the preparation of these derivatives, which allowed for increasing molecular complexity and complete diastereoselective control at C-20 and the substituted sidechains.
Export Options
About this article
Cite this article as:
Pazos Gonzalo, Rivadulla L. Marcos, Perez-García Xenxo, Gandara Zoila and Perez Manuel, Gemini Analogs of Vitamin D, Current Topics in Medicinal Chemistry 2014; 14(21) . https://dx.doi.org/10.2174/1568026615666141208100411
DOI https://dx.doi.org/10.2174/1568026615666141208100411 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Current Pharmaceutical Design Nanotechnology: A Novel Approach for Drug Development in Health Care System
Current Nanomaterials FDG-PET Imaging in Large Vessel Vasculitis and Polymyalgia Rheumatica: A Personal View
Current Immunology Reviews (Discontinued) A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
Current Pharmaceutical Design Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention
Current Pharmaceutical Design Recapitulation of Cancer Nanotherapeutics
Current Nanomedicine Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Aliphatic Nucleophilic Radiofluorination
Current Radiopharmaceuticals Signal Transduction Pathways of Taxanes-Induced Apoptosis
Current Medicinal Chemistry - Anti-Cancer Agents Uncovering New Pharmacological Targets to Treat Neuropathic Pain by Understanding How the Organism Reacts to Nerve Injury
Current Pharmaceutical Design Imaging Virus-Associated Cancer
Current Pharmaceutical Design Gene Therapy Targeting in the Central Nervous System
Current Gene Therapy The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Drug-Glycosidation and Drug Development
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued) Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry